本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Denali Therapeutics Inc.

14.37
-0.0600-0.42%
盤後14.650.2800+1.95%17:25 EDT
成交量:136.79萬
成交額:1,996.94萬
市值:20.88億
市盈率:-5.38
高:15.31
開:14.49
低:14.33
收:14.43
資料載入中...
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/04

重要事件披露

8-K - Current report
2021/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/26

重要事件披露

8-K - Current report
2021/06/04

重要事件披露

8-K - Current report
2021/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03

重要事件披露

8-K - Current report
2021/02/26

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/26

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

重要事件披露

8-K - Current report
2021/02/10

重要事件披露

8-K/A [Amend] - Current report
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

重要事件披露

8-K - Current report
2021/02/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals